首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

無血清培養基市場規模、佔有率和成長分析：按產品類型、培養基類型、應用、細胞類型、最終用戶、配方類型和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2064811

無血清培養基市場規模、佔有率和成長分析：按產品類型、培養基類型、應用、細胞類型、最終用戶、配方類型和地區分類－2026-2033年產業預測

Serum-free Media Market Size, Share, and Growth Analysis, By Product Type (Serum-free Media, Protein-free Media), By Media Type, By Application, By Cell Type, By End User, By Formulation Type, By Region - Industry Forecast 2026-2033

出版日期: 2026年06月11日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球無血清培養基市場價值為 21 億美元，預計到 2025 年將成長至 23.6 億美元，到 2033 年將成長至 59.2 億美元，在預測期（2026-2033 年）內複合年成長率為 12.2%。

全球無血清培養基市場正經歷顯著成長，這主要得益於無需依賴動物源性血清即可促進細胞增殖的配方研發，以及對可重複性、安全性和符合倫理規範的原料日益成長的需求。由於對牛變異性和污染的擔憂，對傳統胎牛血清的依賴性正在降低，從而促使人們開發出適用於CHO細胞和原代人類細胞的預定義替代培養基。這種轉變提高了單株抗體的生產效率和疫苗的大規模生產能力，最大限度地減少了批次間的差異，並有助於符合監管要求。隨著細胞和基因療法需求的加速成長，穩定的生產原料至關重要，這促使人們轉向使用化學成分明確的培養基，以降低免疫抗原性風險並簡化放行檢測流程。因此，對用於無血清配方的單次使用生物反應器的投資正在降低生產成本，並為各個生物技術領域的商業性成長開闢新的途徑。

全球無血清培養基市場促進因素

生物製藥研發中對治療性蛋白質、疫苗和複雜生技藥品的需求不斷成長，推動了無血清培養基的應用。這些培養基能夠提高細胞培養過程的一致性和可重複性。製造商和研究機構傾向於採用預先定義的、不含動物性成分的系統，以簡化製程開發流程，同時滿足監管要求。生物製藥行業的這種激增需求直接促進了提供經驗證的無血清培養基解決方案的製造商的市場成長。這些解決方案能夠確保細胞生長和產品品質的穩定性，並簡化放大和下游工藝，因此正被業內眾多機構廣泛接受。

全球無血清培養基市場的限制因素

除了專用無血清培養基的高成本外，與驗證和製程調整相關的費用也給希望從傳統添加血清系統過渡到無血清培養基的小規模實驗室和預算有限的製造商帶來了巨大挑戰。儘管無血清培養基具有技術優勢，但採購部門在權衡初始投資和預期收益時，往往會因資金限制而阻礙其快速普及。此外，培訓和相容性測試的需求進一步增加了實施成本，造成了財務障礙，使得從傳統培養基操作過渡到無血清培養基時只能分階段進行，而無法一次性完成。因此，許多機構仍然對這些創新解決方案持謹慎態度。

全球無血清培養基市場趨勢

受細胞和基因療法日益普及的推動，全球無血清培養基市場正經歷顯著的發展趨勢。隨著這些創新治療方法的廣泛應用，對預定義、異質性配方的需求日益成長，這些配方為確保治療的一致性、患者安全性和合規性奠定了至關重要的基礎。製造商正致力於提高產品的可重複性並最大限度地減少生物變異性，從而促進內部產品的規模化生產。為此，供應商正在建立客製化的培養基平台，並提供針對特定治療流程的專家技術支援。這種發展不僅加速了商業化進程，也促進了生物技術開發公司與契約製造組織（CMO）之間的策略合作，最終加強了該領域的供應鏈整合。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Thermo Fisher Scientific
Merck KGaA
Danaher Corporation
Lonza Group
FUJIFILM Irvine Scientific
Sartorius
Corning
HiMedia Laboratories
Takara Bio
PromoCell
Miltenyi Biotec
STEMCELL Technologies
CellGenix
PAN-Biotech
Bio-Techne
MP Biomedicals
GE Healthcare
PeproTech
Cyagen Biosciences
BioIVT

結論與建議

簡介目錄

Product Code: SQMIG35J2394

Global Serum-Free Media Market size was valued at USD 2.10 Billion in 2024 and is poised to grow from USD 2.36 Billion in 2025 to USD 5.92 Billion by 2033, growing at a CAGR of 12.2% during the forecast period (2026-2033).

The global serum-free media market is experiencing significant growth driven by the development of formulations that facilitate cell growth without relying on animal-derived serum, addressing the increasing demand for reproducibility, safety, and ethical sourcing. Traditional reliance on fetal bovine serum has waned due to variability and contamination concerns, leading to advancements in defined alternatives suitable for CHO and primary human cells. This shift enhances monoclonal antibody production and large-scale vaccine manufacturing, minimizing batch variability and supporting regulatory compliance. The accelerating demand for cell and gene therapies necessitates consistent manufacturing inputs, prompting a move towards chemically defined media, which reduces immunogenicity risks and streamlines release testing. Consequently, investments in single-use bioreactors for serum-free formulations are driving down production costs and opening new avenues for commercial growth in various biotechnology sectors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Serum-Free Media market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Serum-Free Media Market Segments Analysis

Global serum-free media market is segmented by product type, media type, application, cell type, end user, formulation type and region. Based on by product type, the market is segmented into serum-free media, protein-free media and chemically defined media. Based on by media type, the market is segmented into liquid media, powder media and semi-solid media. Based on by application, the market is segmented into biopharmaceutical production, cell & gene therapy, regenerative medicine, drug discovery & toxicity testing, stem cell research, tissue engineering and others. Based on by cell type, the market is segmented into mammalian cells, stem cells, insect cells, microbial cells and others. Based on by end user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, contract development & manufacturing organizations and others. Based on by formulation type, the market is segmented into customized media and ready-to-use media. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Serum-Free Media Market

The increasing necessity for therapeutic proteins, vaccines, and complex biologics in biopharmaceutical development is propelling the use of serum-free media, as these formulations enhance consistency and reproducibility in cell culture processes. Manufacturers and research laboratories are favoring defined, animal component-free systems to align with regulatory requirements while facilitating the process development. This burgeoning demand from the biopharmaceutical sector directly contributes to the market growth for manufacturers providing validated serum-free media solutions. By ensuring consistent cell growth and product quality, along with simplifying scaling and downstream processing, these solutions are witnessing wider acceptance across various organizations in the industry.

Restraints in the Global Serum-Free Media Market

The high cost associated with specialized serum-free media, coupled with the expenses related to validation and process adjustments, poses a significant challenge for smaller laboratories and budget-conscious manufacturers looking to shift away from traditional serum-supplemented systems. While technical benefits exist, financial constraints often inhibit swift adoption, as procurement teams assess the initial investment against anticipated advantages. Additionally, the requirement for training and compatibility testing further escalates implementation costs, creating a financial obstacle that hampers accelerated market penetration and fosters a gradual rather than a comprehensive transition from established media practices. As a result, many organizations remain hesitant to embrace these innovative solutions.

Market Trends of the Global Serum-Free Media Market

The Global Serum-Free Media market is witnessing a notable trend propelled by the rising adoption of cell and gene therapies. As these innovative treatments gain traction, the demand for defined xeno-free formulations increases, providing an essential foundation for consistency, patient safety, and regulatory compliance. Manufacturers are focusing on enhancing reproducible performance and minimizing biological variability, facilitating the scalable production of autologous products. In response, suppliers are creating customized media platforms and offering specialized technical support tailored to specific therapy workflows. This evolution not only expedites commercialization processes but also encourages strategic partnerships among biotechnology developers and contract manufacturing organizations, ultimately strengthening supply chain integration in the sector.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Serum-free Media Market Size by Product Type & CAGR (2026-2033)

Market Overview
Serum-free Media
Protein-free Media
Chemically Defined Media

Global Serum-free Media Market Size by Media Type & CAGR (2026-2033)

Market Overview
Liquid Media
Powder Media
Semi-solid Media

Global Serum-free Media Market Size by Application & CAGR (2026-2033)

Market Overview
Biopharmaceutical Production
- Monoclonal Antibody Production
- Vaccine Production
- Recombinant Protein Production
- Others
Cell & Gene Therapy
Regenerative Medicine
Drug Discovery & Toxicity Testing
Stem Cell Research
Tissue Engineering
Others

Global Serum-free Media Market Size by Cell Type & CAGR (2026-2033)

Market Overview
Mammalian Cells
Stem Cells
Insect Cells
Microbial Cells
Others

Global Serum-free Media Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations
Contract Development & Manufacturing Organizations
Others

Global Serum-free Media Market Size by Formulation Type & CAGR (2026-2033)

Market Overview
Customized Media
Ready-to-use Media

Global Serum-free Media Market Size & CAGR (2026-2033)

North America (By Product Type, By Media Type, By Application, By Cell Type, By End User, By Formulation Type)
- US
- Canada
Europe (By Product Type, By Media Type, By Application, By Cell Type, By End User, By Formulation Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (By Product Type, By Media Type, By Application, By Cell Type, By End User, By Formulation Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (By Product Type, By Media Type, By Application, By Cell Type, By End User, By Formulation Type)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (By Product Type, By Media Type, By Application, By Cell Type, By End User, By Formulation Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Irvine Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HiMedia Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PromoCell
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CellGenix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PAN-Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MP Biomedicals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PeproTech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyagen Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioIVT
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments